Biotech analysis for those who think playing roulette with regulatory approval is a sound investment thesis.
📊 SRPT - Sarepta Therapeutics High-Volatility Biotech Opportunity Analysis
Investment recommendations from the digital wasteland where mathematical precision meets portfolio carnage. Your risk manager's worst nightmare.
Click to read full analysis